{
    "Trade/Device Name(s)": [
        "AmpliVue Bordetella Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K143206",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133673"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZZ"
    ],
    "Summary Letter Date": "November 6, 2014",
    "Summary Letter Received Date": "November 7, 2014",
    "Submission Date": "November 5, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Bordetella pertussis IS481 nucleic acid"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Helicase-dependent amplification (HDA)",
        "Colorimetric lateral-flow strip detection"
    ],
    "Methodologies": [
        "Isothermal nucleic acid amplification",
        "Hybridization probe",
        "Manual detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Detection system",
        "Cassette",
        "Reagent",
        "Cartridge",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for AmpliVue Bordetella Assay, a qualitative in vitro diagnostic test using helicase-dependent amplification and lateral-flow cassette to detect Bordetella pertussis nucleic acids from nasopharyngeal swabs",
    "Indications for Use Summary": "Qualitative detection of Bordetella pertussis nucleic acids from nasopharyngeal swab specimens of patients suspected of respiratory infection with B. pertussis, for use in hospital, reference, or state laboratory settings",
    "fda_folder": "Microbiology"
}